Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308802 · ClinicalTrials.gov registry record
Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 280
- Enrollment target
NCT00308802 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 280 participants.
The verdict
NCT00308802 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 280 participants
- Enrollment target
Study Summary
The purpose of this study is to test noninvasive methods to monitor the health and condition of new kidneys in people who have received kidney transplants.
Interventions
- PROCEDURE Kidney transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2006-03 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308802
The ClinicalTrials.gov registry entry for NCT00308802 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kidney transplantation is the first listed.
NCT00308802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308802 about?
NCT00308802 is a clinical study titled "Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients". The purpose of this study is to test noninvasive methods to monitor the health and condition of new kidneys in people who have received kidney transplants.
What is the current status of trial NCT00308802?
This trial is currently completed. The enrollment target is 280 participants. The study started on 2006-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00308802?
The interventions under investigation include: Kidney transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00308802?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.